HIKAL Latest Share Price (HIKAL)
TODAY IN ONE LINE
HIKAL dropped 3.6% on average volume, lagging Nifty's -0.5% move, with no exchange filing today, suggesting a market-driven move.
With a market cap of ₹2,501.16 Cr., it trades at a P/E of N/A. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
HIKAL flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Earnings GrowthEPS (TTM) grew by a solid 68.3% YoY
- ●High Promoter HoldingPromoters hold 68.8% skin-in-the-game
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Negative EarningsCompany is reporting negative EPS of ₹-0.60 (Loss Making)
Latest HIKAL News
What changed recently?
Recent events, corporate actions, and announcements.
HIKAL valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for HIKAL, framed against the sector median so the premium or discount is obvious at a glance.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
HIKAL technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for HIKAL — derived from the latest tape, not yesterday's close.
HIKAL last traded at ₹203.18 with an intraday range of ₹201.91–₹212.7 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹203.18| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 231.53 | +28.35 | +13.95% |
| R3 | 220.74 | +17.56 | +8.64% |
| R2 | 216.72 | +13.54 | +6.66% |
| R1 | 209.95 | +6.77 | +3.33% |
| PIVOT | 205.93 | 2.75 | 1.35% |
| CURRENT | 203.18 | — | — |
| S1 | 199.16 | -4.02 | -1.98% |
| S2 | 195.14 | -8.04 | -3.96% |
| S3 | 188.37 | -14.81 | -7.29% |
| S4 | 177.58 | -25.60 | -12.60% |
HIKAL is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹206.83–₹212.7
Trading Below opening range, showing Bearishness
HIKAL financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for HIKAL — consolidated or standalone — with margins, YoY growth and key ratios inline.
HIKAL reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹2,501.16 Cr. and reported EPS of ₹-0.60.
| Metric | Mar 2026 | May 2026 |
|---|---|---|
| Revenue from Operations | 1,713 | 1,713 ▲ 0.0% |
| Sales Growth YoY %Derived | -7.91% | -7.91% |
| Other Income | 12 | 12 ▲ 0.0% |
| Total Income | 1,725 | 1,725 ▲ 0.0% |
| 762 | 762 ▲ 0.0% | |
| Gross ProfitDerived | 951 | 951 ▲ 0.0% |
| Gross Margin %Derived | 55.52% | 55.52% |
| 731 | 731 ▲ 0.0% | |
| EBITDA (Operating Profit)Derived | 220 | 220 ▲ 0.0% |
| OPM %Derived | 12.87% | 12.87% |
| 141 | 141 ▲ 0.0% | |
| Profit Before Tax (PBT) | -78 | -78 ▲ 0.0% |
| -30 | -30 ▲ 0.0% | |
| Effective Tax %Derived | 37.68% | 37.68% |
| Total Profit for Period | -49 | -49 ▲ 0.0% |
| Net Profit (Owner's PAT)Derived | -49 | -49 ▲ 0.0% |
| Net Profit Margin %Derived | -2.85% | -2.85% |
| PAT Growth YoY %Derived | -153.74% | -153.74% |
| Earnings Per Share (EPS ₹) | -3.96 | -3.96 ▲ 0.0% |
| Diluted Shares Outstanding (Cr) | 12 | 12 ▲ 0.0% |
| Other Comprehensive Income (Net of Tax) | -2 | -2 ▲ 0.0% |
| Total Expenses (incl. D&A & Interest) | 1,803 | 1,803 ▲ 0.0% |
| Material Cost % of RevenueDerived | 46.63% | 46.63% |
| Employee Cost % of RevenueDerived | 15.78% | 15.78% |
| Other Cost % of RevenueDerived | 26.87% | 26.87% |
| Interest Coverage (x)Derived | 0.91x | 0.91x |
| Period | Mar 2018 | Jun 2018 | Mar 2019 | May 2019 | Mar 2020 | Jun 2020 | Mar 2021 | May 2021 | Mar 2022 | Mar 2023 | May 2023 | Mar 2024 | May 2024 | Mar 2025 | May 2025 | Mar 2026 | May 2026 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 1,300 | 1,300 ▲ 0.0% | 1,590 ▲ 22.3% | 1,590 ▲ 0.0% | 1,507 ▼ 5.2% | 1,507 ▲ 0.0% | 1,720 ▲ 14.1% | 1,720 ▲ 0.0% | 1,943 ▲ 12.9% | 2,023 ▲ 4.1% | 2,023 ▲ 0.0% | 1,785 ▼ 11.8% | 1,785 ▲ 0.0% | 1,860 ▲ 4.2% | 1,860 ▲ 0.0% | 1,713 ▼ 7.9% | 1,713 ▲ 0.0% | |
| Sales Growth YoY %Derived | — | — | 22.27% | — | -5.18% | — | 14.14% | — | 12.92% | 4.13% | — | -11.79% | -11.79% | 4.21% | 4.21% | -7.91% | -7.91% | |
| Other Income | 4 | 4 ▲ 0.0% | 2 ▼ 49.3% | 2 ▲ 0.0% | 4 ▲ 63.7% | 4 ▲ 0.0% | 5 ▲ 34.6% | 5 ▲ 0.0% | 5 ▼ 1.8% | 5 ▲ 10.6% | 5 ▲ 0.0% | 2 ▼ 54.7% | 2 ▲ 0.0% | 5 ▲ 104.1% | 5 ▲ 0.0% | 12 ▲ 146.0% | 12 ▲ 0.0% | |
| Total Income | 1,305 | 1,305 ▲ 0.0% | 1,592 ▲ 22.0% | 1,592 ▲ 0.0% | 1,511 ▼ 5.1% | 1,511 ▲ 0.0% | 1,725 ▲ 14.2% | 1,725 ▲ 0.0% | 1,948 ▲ 12.9% | 2,028 ▲ 4.2% | 2,028 ▲ 0.0% | 1,787 ▼ 11.9% | 1,787 ▲ 0.0% | 1,865 ▲ 4.4% | 1,865 ▲ 0.0% | 1,725 ▼ 7.5% | 1,725 ▲ 0.0% | |
699 | 699 ▲ 0.0% | 854 ▲ 22.2% | 854 ▲ 0.0% | 776 ▼ 9.1% | 776 ▲ 0.0% | 908 ▲ 17.0% | 908 ▲ 0.0% | 996 ▲ 9.7% | 1,107 ▲ 11.1% | 1,107 ▲ 0.0% | 825 ▼ 25.5% | 825 ▲ 0.0% | 837 ▲ 1.5% | 837 ▲ 0.0% | 762 ▼ 9.0% | 762 ▲ 0.0% | ||
| Gross ProfitDerived | 601 | 601 ▲ 0.0% | 736 ▲ 22.4% | 736 ▲ 0.0% | 731 ▼ 0.7% | 731 ▲ 0.0% | 812 ▲ 11.1% | 812 ▲ 0.0% | 946 ▲ 16.5% | 916 ▼ 3.2% | 916 ▲ 0.0% | 960 ▲ 4.8% | 960 ▲ 0.0% | 1,023 ▲ 6.5% | 1,023 ▲ 0.0% | 951 ▼ 7.0% | 951 ▲ 0.0% | |
| Gross Margin %Derived | 46.24% | 46.24% | 46.29% | 46.29% | 48.49% | 48.49% | 47.20% | 47.20% | 48.71% | 45.28% | 45.28% | 53.79% | 53.79% | 54.98% | 54.98% | 55.52% | 55.52% | |
359 | 359 ▲ 0.0% | 438 ▲ 21.8% | 438 ▲ 0.0% | 458 ▲ 4.6% | 458 ▲ 0.0% | 489 ▲ 6.9% | 489 ▲ 0.0% | 606 ▲ 23.8% | 659 ▲ 8.8% | 659 ▲ 0.0% | 693 ▲ 5.2% | 693 ▲ 0.0% | 694 ▲ 0.2% | 694 ▲ 0.0% | 731 ▲ 5.2% | 731 ▲ 0.0% | ||
| EBITDA (Operating Profit)Derived | 242 | 242 ▲ 0.0% | 298 ▲ 23.3% | 298 ▲ 0.0% | 273 ▼ 8.4% | 273 ▲ 0.0% | 323 ▲ 18.2% | 323 ▲ 0.0% | 341 ▲ 5.5% | 257 ▼ 24.5% | 257 ▲ 0.0% | 267 ▲ 3.9% | 267 ▲ 0.0% | 328 ▲ 23.0% | 328 ▲ 0.0% | 220 ▼ 32.9% | 220 ▲ 0.0% | |
| OPM %Derived | 18.59% | 18.59% | 18.75% | 18.75% | 18.12% | 18.12% | 18.77% | 18.77% | 17.53% | 12.71% | 12.71% | 14.96% | 14.96% | 17.66% | 17.66% | 12.87% | 12.87% | |
135 | 135 ▲ 0.0% | 151 ▲ 12.3% | 151 ▲ 0.0% | 119 ▼ 21.0% | 119 ▲ 0.0% | 121 ▲ 1.6% | 121 ▲ 0.0% | 127 ▲ 4.5% | 157 ▲ 23.8% | 157 ▲ 0.0% | 174 ▲ 10.7% | 174 ▲ 0.0% | 210 ▲ 20.5% | 210 ▲ 0.0% | 141 ▼ 32.8% | 141 ▲ 0.0% | ||
| Profit Before Tax (PBT) | 112 | 112 ▲ 0.0% | 149 ▲ 33.7% | 149 ▲ 0.0% | 127 ▼ 15.1% | 127 ▲ 0.0% | 206 ▲ 63.1% | 206 ▲ 0.0% | 219 ▲ 5.9% | 105 ▼ 51.8% | 105 ▲ 0.0% | 96 ▼ 9.4% | 96 ▲ 0.0% | 124 ▲ 29.6% | 124 ▲ 0.0% | -78 ▼ 163.2% | -78 ▲ 0.0% | |
34 | 34 ▲ 0.0% | 46 ▲ 34.3% | 46 ▲ 0.0% | 42 ▼ 8.4% | 42 ▲ 0.0% | 73 ▲ 73.9% | 73 ▲ 0.0% | 58 ▼ 20.8% | 27 ▼ 53.5% | 27 ▲ 0.0% | 26 ▼ 4.0% | 26 ▲ 0.0% | 33 ▲ 27.4% | 33 ▲ 0.0% | -30 ▼ 189.4% | -30 ▲ 0.0% | ||
| Effective Tax %Derived | 30.74% | 30.74% | 30.86% | 30.86% | 33.29% | 33.29% | 35.50% | 35.50% | 26.56% | 25.61% | 25.61% | 27.12% | 27.12% | 26.66% | 26.66% | 37.68% | 37.68% | |
| Total Profit for Period | 77 | 77 ▲ 0.0% | 103 ▲ 33.4% | 103 ▲ 0.0% | 84 ▼ 18.1% | 84 ▲ 0.0% | 133 ▲ 57.7% | 133 ▲ 0.0% | 161 ▲ 20.5% | 78 ▼ 51.2% | 78 ▲ 0.0% | 70 ▼ 11.2% | 70 ▲ 0.0% | 91 ▲ 30.5% | 91 ▲ 0.0% | -49 ▼ 153.7% | -49 ▲ 0.0% | |
| Net Profit (Owner's PAT)Derived | 77 | 77 ▲ 0.0% | 103 ▲ 33.4% | 103 ▲ 0.0% | 84 ▼ 18.1% | 84 ▲ 0.0% | 133 ▲ 57.7% | 133 ▲ 0.0% | 161 ▲ 20.5% | 78 ▼ 51.2% | 78 ▲ 0.0% | 70 ▼ 11.2% | 70 ▲ 0.0% | 91 ▲ 30.5% | 91 ▲ 0.0% | -49 ▼ 153.7% | -49 ▲ 0.0% | |
| Net Profit Margin %Derived | 5.94% | 5.94% | 6.48% | 6.48% | 5.60% | 5.60% | 7.74% | 7.74% | 8.26% | 3.87% | 3.87% | 3.90% | 3.90% | 4.88% | 4.88% | -2.85% | -2.85% | |
| PAT Growth YoY %Derived | — | — | 33.45% | — | -18.08% | — | 57.70% | — | 20.55% | -51.16% | — | -11.21% | -11.21% | 30.46% | 30.46% | -153.74% | -153.74% | |
| Earnings Per Share (EPS ₹) | 6.26 | 6.26 ▲ 0.0% | 8.36 ▲ 33.5% | 8.36 ▲ 0.0% | 6.85 ▼ 18.1% | 6.85 ▲ 0.0% | 10.80 ▲ 57.7% | 10.80 ▲ 0.0% | 13.02 ▲ 20.6% | 6.36 ▼ 51.2% | 6.36 ▲ 0.0% | 5.64 ▼ 11.3% | 5.64 ▲ 0.0% | 7.36 ▲ 30.5% | 7.36 ▲ 0.0% | -3.96 ▼ 153.8% | -3.96 ▲ 0.0% | |
| Diluted Shares Outstanding (Cr) | 12 | 12 ▲ 0.0% | 12 ▲ 0.0% | 12 ▲ 0.0% | 12 ▲ 0.0% | 12 ▲ 0.0% | 12 ▲ 0.0% | 12 ▲ 0.0% | 12 ▲ 0.0% | 12 ▲ 0.0% | 12 ▲ 0.0% | 12 ▲ 0.0% | 12 ▲ 0.0% | 12 ▲ 0.0% | 12 ▲ 0.0% | 12 ▲ 0.0% | 12 ▲ 0.0% | |
| Other Comprehensive Income (Net of Tax) | 0 | 0 ▲ 0.0% | 0 ▲ 233.3% | 0 ▲ 0.0% | -0 ▼ 230.0% | -0 ▲ 0.0% | -1 ▼ 1007.7% | -1 ▲ 0.0% | 1 ▲ 183.3% | -1 ▼ 146.7% | -1 ▲ 0.0% | -1 ▼ 8.9% | -1 ▲ 0.0% | -1 ▼ 129.5% | -1 ▲ 0.0% | -2 ▼ 71.4% | -2 ▲ 0.0% | |
| Total Expenses (incl. D&A & Interest) | 1,193 | 1,193 ▲ 0.0% | 1,443 ▲ 20.9% | 1,443 ▲ 0.0% | 1,384 ▼ 4.0% | 1,384 ▲ 0.0% | 1,519 ▲ 9.7% | 1,519 ▲ 0.0% | 1,729 ▲ 13.8% | 1,923 ▲ 11.2% | 1,923 ▲ 0.0% | 1,692 ▼ 12.0% | 1,692 ▲ 0.0% | 1,741 ▲ 2.9% | 1,741 ▲ 0.0% | 1,803 ▲ 3.6% | 1,803 ▲ 0.0% | |
| Material Cost % of RevenueDerived | 55.02% | 55.02% | 54.65% | 54.65% | 51.88% | 51.88% | 52.70% | 52.70% | 53.13% | 55.44% | 55.44% | 45.12% | 45.12% | 47.46% | 47.46% | 46.63% | 46.63% | |
| Employee Cost % of RevenueDerived | 9.85% | 9.85% | 9.46% | 9.46% | 10.39% | 10.39% | 9.55% | 9.55% | 10.47% | 11.00% | 11.00% | 13.81% | 13.81% | 13.29% | 13.29% | 15.78% | 15.78% | |
| Other Cost % of RevenueDerived | 17.79% | 17.79% | 18.07% | 18.07% | 19.98% | 19.98% | 18.88% | 18.88% | 20.71% | 21.58% | 21.58% | 25.01% | 25.01% | 24.03% | 24.03% | 26.87% | 26.87% | |
| Interest Coverage (x)Derived | 3.18x | 3.18x | 3.51x | 3.51x | 3.64x | 3.64x | 6.56x | 6.56x | 7.85x | 3.08x | 3.08x | 2.65x | 2.65x | 2.58x | 2.58x | 0.91x | 0.91x |
HIKAL segment analysis : revenue and profit mix.
Disclosed business segments at HIKAL with their share of revenue and profit, switchable between consolidated and standalone reporting.
HIKAL discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for HIKAL.
Our AI distills the core fundamental drivers supporting HIKAL, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
HIKAL's investment case rests on 0 positive markers and 1 flagged concerns drawn from the latest reported filings.
What you're getting.
No strengths or opportunities on record.
Key Risks.
SWOT generation temporarily unavailable due to model error. Bedrock invocation timeout
Flip Conditions.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.07. Balance sheet risk re-prices growth multiples fast.
Income thesis breaks if the dividend is cut or yield falls below 0.14%.
HIKAL peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — HIKAL is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
HIKAL chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for HIKAL — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
HIKAL delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for HIKAL over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in HIKAL stood at 42.6% of traded volume, against a 20-day average of 39.2%.
HIKAL announcements: results, concalls, ratings, M&A.
Filings HIKAL sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
HIKAL files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 163 documents below.
Copy of Newspaper Publication
Hikal Limited has informed the Exchange about Copy of Newspaper Publication
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Hikal Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Resignation of Director/KMP/SMP
Hikal Limited has informed the Exchange about Resignation of Director/KMP/SMP
Outcome of Board Meeting
Hikal Limited has informed the Exchange regarding Outcome of Board Meeting held on October 01, 2026.
General Updates
Hikal Limited has informed the Exchange about General Updates
Investor decks & rating reports.
Analysts/Institutional Investor Meet/Con. Call Updates
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation
Investor Presentation
HIKAL dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue HIKAL has declared, sequenced by announce and record date.
HIKAL corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About HIKAL: business, sector, key facts.
What HIKAL does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
HIKAL operates in the Pharmaceuticals industry under the Healthcare sector, listed as NSE: HIKAL, BSE: 524735.
Hikal Limited is a global manufacturer and supplier of a diverse range of chemical products, primarily serving the pharmaceutical, animal health, crop protection, and specialty chemicals industries. Their operations span across multiple continents, including India, the United States, Canada, Europe, and Southeast Asia, showcasing a significant international presence and market reach.
The company's business is structured into two key segments: Pharmaceuticals and Crop Protection. The Pharmaceuticals segment focuses on the production of Active Pharmaceutical Ingredients (APIs), which are crucial components in the creation of various medications. This segment contributes significantly to the global pharmaceutical supply chain by providing essential building blocks for numerous drugs.
The Crop Protection segment manufactures a broad spectrum of pesticides and herbicides, including notable products such as diuron tech, temephos tech, and several others. These products cater to the agricultural sector, aiding in crop protection and yield enhancement. The breadth of their offerings within this segment establishes Hikal as a key player in the agrochemical industry.
Beyond its core manufacturing activities, Hikal also provides comprehensive contract research and custom synthesis services. This allows them to offer tailored solutions for clients requiring specific chemical intermediates or active ingredients, strengthening their position as a versatile partner for various industries. They further expand their services to include custom manufacturing, catering to clients' specialized needs.
Hikal's product portfolio extends beyond APIs and agrochemicals. They also offer a range of human and animal health products, including a variety of medications addressing different therapeutic areas. Additionally, they supply specialty biocides and antimicrobial actives, along with additives for diverse industries such as leather, paint, paper, water treatment, personal care, building materials, and textiles, demonstrating the breadth and versatility of their chemical manufacturing capabilities.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- AAREY DRUGS & PHARM (AAREYDRUGS) Share PricePeer
- AARTI DRUGS (AARTIDRUGS) Share PricePeer
- AARTI PHARMALABS (AARTIPHARM) Share PricePeer
- AJANTA PHARMA (AJANTPHARM) Share PricePeer
- AKUMS DRUGS AND PHARMA L (AKUMS) Share PricePeer
- Top Losers TodayScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about HIKAL (HIKAL).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of HIKAL (HIKAL)?
The current share price of HIKAL (HIKAL) is ₹203.18. Today, the stock has declined by ₹7.58 (3.6%), trading in a range of ₹201.91 to ₹212.70. The stock opened at ₹210.05 with a trading volume of 3,28,523 shares.
02Is HIKAL stock a good investment for long-term?
HIKAL can be considered for long-term investment based on several factors. The company has a market capitalization of ₹2,501.16 Cr., P/E ratio of 0, ROE of -4.07%, and ROCE of -0.87%. The dividend yield stands at 0.28%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of HIKAL stock?
The 52-week high price of HIKAL (HIKAL) is ₹261.00, while the 52-week low is ₹146.25. Currently trading at ₹203.18, the stock is 38.93% above its 52-week low and 22.15% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy HIKAL stock at the current price?
Whether to buy HIKAL stock at ₹203.18 depends on multiple factors. The stock is currently trading with a P/E ratio of 0 and P/B ratio of 2.09. Today's performance shows a loss of 3.6%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of HIKAL and when is the next dividend?
HIKAL offers a dividend yield of 0.28%, which means for every ₹100 invested at the current price of ₹203.18, you can expect to receive approximately ₹0.28 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of HIKAL?
HIKAL's key financial metrics include: P/E Ratio: 0, P/B Ratio: 2.09, ROE: -4.07%, ROCE: -0.87%, Dividend Yield: 0.28%, EPS: ₹-0.60, Book Value: ₹97.23, and Debt-to-Equity: 0.57. The company's market cap stands at ₹2,501.16 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is HIKAL stock performing today in the market?
HIKAL stock opened at ₹210.05 and is currently trading at ₹203.18, showing a decline of ₹7.58 (3.6%). The intraday high is ₹212.70 and low is ₹201.91. The trading volume stands at 3,28,523 shares, indicating moderate market participation today.
08What is the P/E ratio of HIKAL and what does it indicate?
HIKAL has a Price-to-Earnings (P/E) ratio of 0, which means investors are willing to pay 0.00 for every ₹1 of earnings. With an EPS of ₹-0.60, this P/E ratio suggests the stock may be undervalued or facing growth challenges. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about HIKAL (HIKAL) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.